• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.32% Nasdaq Down 0.01%

    Immune Pharmaceuticals, Inc. (IMNP)

    -NasdaqCM
    1.66 Down 0.05(2.92%) Jul 31, 3:59PM EDT
    Add to Portfolio
    Prev Close:1.71
    Open:1.77
    Bid:N/A
    Ask:1.79 x 1100
    1y Target Est:6.00
    Beta:1.79
    Next Earnings Date:N/A
    Day's Range:1.62 - 1.79
    52wk Range:1.50 - 4.20
    Volume:56,582
    Avg Vol (3m):206,203
    Market Cap:40.92M
    P/E (ttm):N/A
    EPS (ttm):-1.20
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for IMNP

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.56
    Quarterly EPS Est (Jun-15) :-0.25
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Immune Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops and commercializes targeted therapeutics for the treatment of inflammatory diseases and cancer. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback